Diagnosis and management of the growing teratoma syndrome: A single-center experience and review of the literature
Testicular germ cell tumors are the most common solid neoplasms among young men with the highest incidence between the second and fourth decade [1]. Due to effective cisplatin-based chemotherapy and a risk-adapted interdisciplinary treatment approach, testicular cancer has a high cure rate even in advanced stages [1]. However, a small number of patients that receive cisplatin-based chemotherapy for metastatic nonseminomatous germ cell tumors (NSGCT) show growing metastatic masses despite normalized or decreasing tumor markers [2].
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Pia Paffenholz, David Pfister, Vsevolod Matveev, Axel Heidenreich Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Germ Cell Tumors | Teratoma | Testicular Cancer | Urology & Nephrology